Evidence map›Paper›PMID 36212532›Full record

ArticleComputational and structural biotechnology journal2022

Pairwise sequence similarity mapping with PaSiMap: Reclassification of immunoglobulin domains from titin as case study.

Kathy Su, Olga Mayans, Kay Diederichs, Jennifer R Fleming

Abstract read
In one paragraph

Article in Computational and structural biotechnology journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Molecular insights into titin's A-band.Journal of muscle research and cell motility · 2023
    Article
  5. PK1 fromOpen biology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kathy SuDepartment of Biology, Universität Konstanz, Konstanz, Baden Württemberg 78456, Germany.
Olga MayansDepartment of Biology, Universität Konstanz, Konstanz, Baden Württemberg 78456, Germany.
Kay DiederichsDepartment of Biology, Universität Konstanz, Konstanz, Baden Württemberg 78456, Germany.
Jennifer R FlemingDepartment of Biology, Universität Konstanz, Konstanz, Baden Württemberg 78456, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sequence comparison is critical for the functional assignment of newly identified protein genes. As uncharacterized protein sequences accumulate, there is an increasing need for sensitive tools for their classification. Here, we present a novel multidimensional scaling pipeline, PaSiMap, which creates a map of pairwise sequence similarities. Uniquely, PaSiMap distinguishes between unique and shared features, allowing for a distinct view of protein-sequence relationships. We demonstrate PaSiMap's efficiency in detecting sequence groups and outliers using titin's 169 immunoglobulin (Ig) domains. We show that Ig domain similarity is hierarchical, being firstly determined by chain location, then by the loop features of the Ig fold and, finally, by super-repeat position. The existence of a previously unidentified domain repeat in the distal, constitutive I-band is revealed. Prototypic Igs, plus notable outliers, are identified and thereby domain classification improved. This re-classification can now guide future molecular research. In summary, we demonstrate that PaSiMap is a sensitive tool for the classification of protein sequences, which adds a new perspective in the understanding of inter-protein relationships. PaSiMap is applicable to any biological system defined by a linear sequence, including polynucleotide chains.

Indexed as

Multidimensional scalingSequence analysisTitin

Identifiers

PMID36212532
PMCPMC9529554

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.